TrialPath
← All studies
Depression

DBS for Depression

Recruiting · Dallas, Houston, Texas

Always free

Study care at no cost to you

For your time and travel

Many studies pay you back

Most need no insurance or papers

Legal status usually isn't required; we'll tell you each study's requirements

Interpreters available

Ask for your language

Your choice

Voluntary — you can stop anytime

What is this study?

The goal of the study is to address the unmet need of TRD patients by identifying brain networks critical for treating depression and to use next generation precision DBS with steering capability to engage these targeted networks. The study's goal will be achieved through 3 specific aims: 1.

It is , overseen by an independent and licensed medical staff.

Read the full clinical description

The goal of the study is to address the unmet need of TRD patients by identifying brain networks critical for treating depression and to use next generation precision DBS with steering capability to engage these targeted networks. The study's goal will be achieved through 3 specific aims: 1. Demonstrate device capability to selectively and predictably engage distinct brain networks 2. Delineate depression-relevant networks and demonstrate behavioral changes with network-targeted stimulation 3. Demonstrate that chronic DBS using steered, individualized targeting is feasible and safe for reducing depressive symptoms

Who this study is looking for

In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.

✅ You may be able to join if…

  • Men and women (not pregnant) ages 22 to 70
  • Diagnosis of major depression disorder (MDD) as the main diagnosis, with a current major depressive episode
  • Depression that has lasted at least 24 months (current) and/or depression that keeps coming back, plus treatment resistance based on the Antidepressant Treatment History Form (ATHF)
  • At screening, depression symptom severity is high (HDRS-17 score is at least 20), and it stays high on two assessments
  • Have had electroconvulsive therapy (ECT) before (it did not help, or it came back, or it was not tolerated, or you refused), and have a recent brain MRI within 3 months that is considered normal or not disqualifying

🚫 You may not be able to join if…

  • Any lifetime history of a psychotic disorder (like schizophrenia or schizoaffective disorder)
  • Bipolar disorder with rapid cycling and a manic episode that required hospitalization in the past 5 years
  • A history of alcohol or substance use disorder within the past 6 months (except nicotine) or a positive urine drug test for illicit drugs
  • Suicidal intent, suicide attempt, or suicidal behavior within the past year
  • Pregnant (or plans to become pregnant in the next 24 months), or unable to undergo surgery safely (for example, certain bleeding problems, very high blood pressure, infection, seizure risk, or implanted devices like pacemakers/defibrillators/neurostimulators/DBS)

Are you a good fit?

Simplified highlights. The study team always confirms the full details with you.

  • Adults roughly 22–70
  • Have Depression
  • !Some conditions may not be a fit: Heart / cardiovascular disease
  • !Not for people who are pregnant or breastfeeding

What to expect, step by step

  1. 1

    Usually a few weeks

    The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.

  2. 2

    Treatment

    If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.

  3. 3

    Follow-up

    After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.

Has this treatment been tested before?

The study team can share what safety testing has been done so far.

What you need to know before you apply

What is this study testing?+

The goal of the study is to address the unmet need of TRD patients by identifying brain networks critical for treating depression and to use next generation precision DBS with steering capability to engage these targeted networks. The study's goal will be achieved through 3 specific aims: 1.

Is it safe? Who makes sure of that?+

This is a research study. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.

Will I get a placebo instead of the real treatment?+

Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.

Do I have to stop taking my current medications?+

It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.

Does it cost anything? Will I be paid?+

Study-related care is provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.

Do I need insurance? Will anyone ask about my immigration status?+

No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.

What if English isn't my first language?+

You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.

Is my information private?+

Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.

Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.

Source: ClinicalTrials.gov · NCT03437928 · Locations: Texas